These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4957166)

  • 1. Cardiac and renal hemodynamic effects of the antifibrinolytic agent, epsilon aminocaproic acid.
    Swartz C; Onesti G; Ramirez O; Shah N; Brest AN
    Curr Ther Res Clin Exp; 1966 Jul; 8(7):336-42. PubMed ID: 4957166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of epsilon-aminocaproic acid on cerebral hemodynamics].
    Eninia GI; Metra MIa; Gaĭle NV
    Klin Med (Mosk); 1979 Sep; 57(9):57-9. PubMed ID: 491515
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antihemorrhagic agent of choice in pediatric ENT: capramol Choay (epsilon-aminocaproic acid)].
    Berger M; Pinson
    J Med Bord; 1965 Apr; 142(4):719-21. PubMed ID: 5318696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological research on derivatives of epsilon-aminocaproic acid. I. Action on the cardiovascular system of 3-4-5-trimethoxy-benzoyl-epsilon-aminocaproci acid].
    Razzaboni G; Setti L; Tamiso R
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1783-5. PubMed ID: 5733068
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of antifibrinolytic effects of epsilon-aminocaproic acid and enzyme inhibitors in the surgery of portal hypertension].
    Lande M; Clot-Paimboeuf C; Dentan T
    Presse Med (1893); 1971 Jan; 79(1):15-6. PubMed ID: 5539954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of coxarthrosis with epsilon aminocaproic acid].
    Sturm G; Voigt B
    Beitr Orthop Traumatol; 1972 Oct; 19(10):609-12. PubMed ID: 4569051
    [No Abstract]   [Full Text] [Related]  

  • 7. [The administration of epsilon-aminocaproic acid in hemophelia].
    van Creveld S; de Vos-Bongaardt CM
    Maandschr Kindergeneeskd; 1966 Sep; 34(9):285-9. PubMed ID: 5341361
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trial with epsilon-aminocaproic acid in psoriasis vulgaris].
    Rowe E; Meffert H; Wischnewsky GG; Buchholz W
    Dermatol Monatsschr; 1985; 171(4):230-2. PubMed ID: 3891434
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of epsilon aminocaproic acid as an adjunct to replacement therapy in hemophiliacs undergoing tooth extraction. (Part I).
    Evans BE
    N Y J Dent; 1981 Mar; 51(3):83-90. PubMed ID: 7010243
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of epsilon-aminocaproic acid in the treatment of acute pancreatits].
    Karavanov AG; Osingolts SL
    Klin Med (Mosk); 1966 May; 44(5):13-5. PubMed ID: 4865586
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic activity in hemophilia and the use of epsilon-aminocaproic acid.
    Ritz ND
    N Y State J Med; 1965 Dec; 65(23):2914-25. PubMed ID: 5320118
    [No Abstract]   [Full Text] [Related]  

  • 12. The preventative effect of the antifibrinolytic agents, epsilon-aminocaproic acid and tranexamic acid, on stress ulcer formation in rats.
    Kodama Y; Kumashiro R; Gain T; Matsumoto T
    Int Surg; 1983; 68(4):361-3. PubMed ID: 6668161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of epsilon-aminocaproic acid hydrochloride in hemorrhage in urological patients].
    Shemetov VD
    Sov Zdravookhr Kirg; 1970; 1():62-4. PubMed ID: 5447557
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibitors of fibrinolysis. (Our experience with epsilon-aminocaproic acid and the Kunitz inhibitor)].
    Babío San Salvador JL; Iriarte Ezcurdia JA; Ezcurra Cebreiro JM
    Rev Clin Esp; 1965 Nov; 99(4):249-52. PubMed ID: 5863279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of zinc epsilon-acetamidocaproate (A-84) in duodenal ulcer].
    Roig Catalá E; Iborra Baviera J; Errando Mariscal J; Lerma Berenguer J
    Rev Esp Enferm Apar Dig; 1984 Oct; 66(4):302-6. PubMed ID: 6393239
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epsilon-aminocaproic acid and trasylol as hemostyptic agents in prostatic surgery].
    Schmutzler R; Fürstenberg H
    Helv Chir Acta; 1966 Aug; 33(4):478-83. PubMed ID: 5300406
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifibrinolytic control of menorrhagia after I.U.D. insertion.
    MacMath IF
    Practitioner; 1973 Mar; 210(257):417-20. PubMed ID: 4571360
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renal complications during treatment of hematuria in hemophilia A with epsilon-aminocaproic acid (EACA)].
    Liskiewicz Z; Maj S; Ziemski JM
    Pol Tyg Lek; 1971 Jan; 26(4):145-7. PubMed ID: 5101008
    [No Abstract]   [Full Text] [Related]  

  • 19. Salt-sensitive hypertension: renal and cardiovascular implications.
    Campese VM
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):143-56. PubMed ID: 10464787
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic and hemodynamic changes associated with the administration of epsilon amino caproic acid.
    Tice DA; Redisch W; Carroll HJ
    Surg Forum; 1965; 16():59-60. PubMed ID: 5835248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.